Altamont Pharmaceutical Holdings Overview
- Investor Type
-
Holding Company
- Status
-
Active
- Professionals
-
1
- Investments
-
22
- Portfolio
-
4
- Exits
-
20
Altamont Pharmaceutical Holdings General Information
Company Description
Altamont Pharmaceutical Holdings is a healthcare investment firm that seeks to invest in biotech companies with an emphasis on private investment in public equity (PIPE) offerings. The company invests in the vision of entrepreneurs and scientists to cure life-threatening diseases and reduce the effects of chronic disease. The firm was founded in 2017 and it is based in Austin, Texas.
Business Details
Website
www.altamontpharma.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 600 Congress Avenue
- 14th Floor
- Austin, TX 78701
- United States
Altamont Pharmaceutical Holdings Investments (22)
Altamont Pharmaceutical Holdings’s most recent investment was a with IO Biotech for . The deal was made on 11-Aug-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| IO Biotech | 11-Aug-2023 | Drug Discovery | Bankruptcy: Liquidation | |||
| Dialectic Therapeutics | 01-Mar-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Cessation Therapeutics | 11-May-2022 | Drug Discovery | Generating Revenue | |||
| Angarus Therapeutics | 22-Jun-2021 | Drug Discovery | Out of Business | |||
| Amygdala Neurosciences | 28-Apr-2021 | Seed Round | Drug Discovery | Pre-Clinical Trials |
Altamont Pharmaceutical Holdings Exits (20)
Altamont Pharmaceutical Holdings has made a total of 20 exits. Its latest exit was from IO Biotech on 01-Apr-2026. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| IO Biotech | 01-Apr-2026 | ||
| InflaRx | 18-Feb-2025 | ||
| MeiraGTx | 12-Aug-2024 | ||
| DTech Liquidating | 18-Jun-2024 | ||
| Urogen Pharma | 17-Jun-2024 | Public Investment 2nd Offering |
Altamont Pharmaceutical Holdings Investments by Industry, Year, and Region
Altamont Pharmaceutical Holdings FAQs
-
What is Altamont Pharmaceutical Holdings?
Altamont Pharmaceutical Holdings is a healthcare investment firm that seeks to invest in biotech companies with an emphasis on private investment in public equity (PIPE) offerings.
-
When was Altamont Pharmaceutical Holdings founded?
Altamont Pharmaceutical Holdings was founded in 2017.
-
Where is Altamont Pharmaceutical Holdings headquartered?
Altamont Pharmaceutical Holdings is headquartered in Austin, TX.
-
How many investments has Altamont Pharmaceutical Holdings made?
Altamont Pharmaceutical Holdings has made 22 investments.
-
What has Altamont Pharmaceutical Holdings invested in?
Altamont Pharmaceutical Holdings has made numerous investments in companies like IO Biotech, Dialectic Therapeutics, and Cessation Therapeutics within the Drug Discovery industry.
-
What has Altamont Pharmaceutical Holdings invested in recently?
Altamont Pharmaceutical Holdings's latest investment was on 11-Aug-2023 in IO Biotech, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process